Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian M Thompson

Showing results (391-400 of 484) with videos related to

Pageof 49
Sort By:
Carcinogenesis|December 12, 2017
Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention TrialLi Tang, Mary E Platek, Song Yao, et al.
The Journal of Urology|June 9, 2025
Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening: ErratumJohn T Wei, Daniel Barocas, Sigrid Carlsson, et al.
European Urology|November 28, 2016
Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance StudyDaniel W Lin, Lisa F Newcomb, Marshall D Brown, et al.
The Journal of Urology|April 25, 2023
Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate BiopsyJohn T Wei, Daniel Barocas, Sigrid Carlsson, et al.
The Journal of Urology|October 19, 2010
Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trialDouglas K Price, Cindy H Chau, Cathee Till, et al.
Plos One|May 9, 2015
Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention TrialCindy H Chau, Douglas K Price, Cathee Till, et al.
Plos One|July 15, 2015
Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 PatientsJames D Brooks, Wei Wei, Sarah Hawley, et al.
The Journal of Urology|April 25, 2023
Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer ScreeningJohn T Wei, Daniel Barocas, Sigrid Carlsson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2012
Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasterideAlan R Kristal, Cathee Till, Catherine M Tangen, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2022
Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsyStefan E Eng, Benjamin Basasie, Alfonso Lam, et al.
Pageof 49

Showing results (391-400 of 484) with videos related to

Sort By:
Pageof 49
Carcinogenesis|December 12, 2017
Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention TrialLi Tang, Mary E Platek, Song Yao, et al.
The Journal of Urology|June 9, 2025
Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening: ErratumJohn T Wei, Daniel Barocas, Sigrid Carlsson, et al.
European Urology|November 28, 2016
Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance StudyDaniel W Lin, Lisa F Newcomb, Marshall D Brown, et al.
The Journal of Urology|April 25, 2023
Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate BiopsyJohn T Wei, Daniel Barocas, Sigrid Carlsson, et al.
The Journal of Urology|October 19, 2010
Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trialDouglas K Price, Cindy H Chau, Cathee Till, et al.
Plos One|May 9, 2015
Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention TrialCindy H Chau, Douglas K Price, Cathee Till, et al.
Plos One|July 15, 2015
Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 PatientsJames D Brooks, Wei Wei, Sarah Hawley, et al.
The Journal of Urology|April 25, 2023
Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer ScreeningJohn T Wei, Daniel Barocas, Sigrid Carlsson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2012
Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasterideAlan R Kristal, Cathee Till, Catherine M Tangen, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2022
Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsyStefan E Eng, Benjamin Basasie, Alfonso Lam, et al.
Pageof 49